Guanhao BiotechLtd Valuation
Is 300238 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Share Price vs Fair Value
What is the Fair Price of 300238 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300238?
Other financial metrics that can be useful for relative valuation.
| What is 300238's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 9.8x |
| Enterprise Value/EBITDA | 126.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 300238's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9.8x | ||
000710 Berry GenomicsLtd | 3.1x | n/a | CN¥3.5b |
000504 Landfar Bio-medicine | 26.9x | n/a | CN¥3.3b |
300439 Medicalsystem Biotechnology | 2.4x | n/a | CN¥4.4b |
300683 Wuhan Hiteck Biological PharmaLtd | 6.8x | n/a | CN¥4.2b |
300238 Guanhao BiotechLtd | 10x | n/a | CN¥3.7b |
Price to Earnings Ratio vs Industry
How does 300238's PE Ratio compare vs other companies in the CN Biotechs Industry?
Price to Sales Ratio vs Fair Ratio
What is 300238's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 10x |
| Fair PS Ratio | n/a |
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?